Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
GSK plans ‘some limited impact’ to UK roles from restructuring
GSK’s global restructuring plan is likely to see “some limited impact” to roles on the Big Pharma’s home turf of the U.K., executives have confirmed.
James Waldron
Oct 28, 2026 6:33am
From RAS rivalry to leaked readouts, ESMO brought the data drama
Oct 27, 2026 8:00am
GSK’s B7-H3 ADC drives 67% cancer risk reduction in phase 3
Oct 27, 2026 3:28am
ESMO: GSK cancer R&D chief says data ‘reinforces belief’ in mo-rez
Oct 23, 2026 6:05pm
GSK's Waterhouse tapped to helm struggling CSL—Chutes & Ladders
Oct 23, 2026 8:30am
Amid bepirovirsen triumph, GSK scraps trial of next-gen therapy
Oct 21, 2026 9:35am